logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12514909 B1

PDFFull Text
Date of Patent:
Jan. 06, 2026

Filed:

Aug. 27, 2019

Lactate-protected hypoglycemia to treat glycolysis dependent pathological conditions, in particular cancer

Applicant:

Laca Medical B.v., Groningen, NL;

Inventors:

Jakob Kampinga, Groningen, NL;

Maarten Willem Nicolaas Nijsten, Groningen, NL;

Antonio Maria Pesenti, Milan, IT;

Alberto Zanella, Lissone, IT;

Assignee:

LACA MEDICAL B.V., Groningen, NL;

Attorney:

KDW Firm PLLC

Primary Examiner:

Julie Ha

Assistant Examiner:

Kristina M Hellman

Int. Cl.
CPC ...
A61K 38/28 (2006.01); A61K 9/00 (2006.01); A61K 31/155 (2006.01); A61K 31/191 (2006.01); A61K 31/7004 (2006.01); A61K 45/06 (2006.01); A61P 33/00 (2006.01); A61P 35/00 (2006.01);
U.S. Cl.
CPC ...
A61K 38/28 (2013.01); A61K 9/0019 (2013.01); A61K 31/155 (2013.01); A61K 31/191 (2013.01); A61K 31/7004 (2013.01); A61K 45/06 (2013.01);
Abstract

A kit includes the components lactic acid, insulin and glucose, and optionally one or more components selected from a glucagon inhibitor, an alpha-beta adrenergic blocker and an antidiabetic agent, for treating a glycolysis-dependent pathological condition in a human or animal. A treatment includes intravascular, in particular intravenous, delivery of the components lactic acid, insulin and glucose into the circulation of the human or animal to be treated to induce hypoglycemia and hyperlactatemia. The glycolysis-dependent pathological condition is selected from the group consisting of cancer, bacterial infection or parasite infection.

Find Patent Forward Citations

Kampinga, Jakob. (2026). Lactate-protected hypoglycemia to treat glycolysis dependent pathological conditions, in particular cancer (U.S. Patent No. 12514909). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12514909

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…